Roxithromycin inhibits chemokine-induced chemotaxis of Th1 and Th2 cells but regulatory T cells

Journal of Dermatological Science

Volumn 54, Issue 3, 2009, Pages 185-191

  Ito, Taisuke ^a   Ito, Natsuho ^a   Hashizume, Hideo ^a   Takigawa, Masahiro ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Chemotaxis; IP 10; Macrolide; Roxithromycin; TARC

Indexed keywords

CALCIUM; CHEMOKINE; CHEMOKINE RECEPTOR CCR4; CHEMOKINE RECEPTOR CXCR3; CLARITHROMYCIN; ERYTHROMYCIN; F ACTIN; GAMMA INTERFERON INDUCIBLE PROTEIN 10; ROXITHROMYCIN; THYMUS AND ACTIVATION REGULATED CHEMOKINE;

ACTIN POLYMERIZATION; ADULT; ARTICLE; CALCIUM TRANSPORT; CELL MIGRATION; CHEMOTAXIS; DOWN REGULATION; DRUG EFFECT; DRUG MECHANISM; ENZYME REPRESSION; FEMALE; HUMAN; HUMAN CELL; INCUBATION TIME; MALE; NORMAL HUMAN; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; TH1 CELL; TH2 CELL;

ACTINS; ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIOXIDANTS; CALCIUM; CELLS, CULTURED; CHEMOKINES; CHEMOTAXIS; FEMALE; HUMANS; IMMUNOLOGIC FACTORS; MALE; MIDDLE AGED; RECEPTORS, CHEMOKINE; ROXITHROMYCIN; T-LYMPHOCYTES, REGULATORY; TH1 CELLS; TH2 CELLS;

EID: 67349258509     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2009.01.007     Document Type: Article

References (31)

1. Epstein M.E., Amodio-Groton M., and Sadick N.S. Antimicrobial agents for the dermatologist. II: Macrolides, fluoroquinolones, rifamycins, tetracyclines, trimethoprim-sulfamethoxazole, and clindamycin. J Am Acad Dermatol 37 (1997) 365-381
2. Bell S.C., Senini S.L., and McCormack J.G. Macrolides in cystic fibrosis. Chronic Resp Dis 2 (2005) 85-98
3. Takahashi H., Suzuki Y., Miyauchi Y., Hashimoto Y., Ishida-Yamamoto A., and Iizuka H. Roxithromycin decreases ultraviolet B irradiation-induced reactive oxygen intermediates production and apoptosis of keratinocytes. J Dermatol Sci 34 (2004) 25-33
4. Asano K., Kamakazu K., Hisamitsu T., and Suzaki H. Modulation of Th2 type cytokine production from human peripheral blood leukocytes by a macrolide antibiotic, roxithromycin, in vitro. Int Immunopharmacol 1 (2001) 1913-1921
5. Konno S., Adachi M., Asano K., Okamoto K., and Takahashi T. Anti-allergic activity of roxithromycin: inhibition of interleukin-5 production from mouse T lymphocytes. Life Sci 52 (1993) 25-30
6. Urasaki Y., Nori M., Iwata S., Sasaki T., Hosono O., Kawasaki H., et al. Roxithromycin specifically inhibits development of collagen induced arthritis and production of proinflammatory cytokines by human T cells and macrophages. J Rheumatol 32 (2005) 1765-1774
7. Wakita H., Tokura Y., Furukawa F., and Takigawa M. The macrolide antibiotic, roxithromycin suppresses IFN-gamma-mediated immunological functions of cultured normal human keratinocytes. Biol Pharm Bull 19 (1996) 224-227
8. Ohshima A., Takigawa M., and Tokura Y. CD8+ cell changes in psoriasis associated with roxithromycin-induced clinical improvement. Eur J Dermatol 11 (2001) 410-415
9. Komine M., and Tamaki K. An open trial of oral macrolide treatment for psoriasis vulgaris. J Dermatol 27 (2000) 508-512
10. Komiya N., and Tamaoki K. Therapeutic effects of macrolides on patients with psoriasis vulgaris, pigmentary prurigo, or eosinophilic pustule folliculitis. Jpn J Antibiot 54 Suppl. A (2001) 100-102
11. Aggarwal B.B., Shishodia S., Sandur S.K., Pandey M.K., and Sethi G. Inflammation and cancer: how hot is the link?. Biochem Pharmacol 72 (2006) 1605-1621
12. Sallusto F., Lenig D., Mackay C.R., and Lanzavecchia A. Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes. J Exp Med 187 (1998) 875-883
13. Komine M., Kakinuma T., Kagami S., Hanakawa Y., Hashimoto K., and Tamaki K. Mechanism of thymus- and activation-regulated chemokine (TARC)/CCL17 production and its modulation by roxithromycin. J Invest Dermatol 125 (2005) 491-498
14. Kobayashi M., Shimauchi T., Hino R., and Tokura Y. Roxithromycin downmodulates Th2 chemokine production by keratinocytes and chemokine receptor expression on Th2 cells: its dual inhibitory effects on the ligands and the receptors. Cell Immunol 228 (2004) 27-33
15. Santangelo S., Cousins D.J., Winkelmann N.E., and Staynov D.Z. DNA methylation changes at human Th2 cytokine genes coincide with DNase I hypersensitive site formation during CD4(+) T cell differentiation. J Immunol 169 (2002) 1893-1903
16. McHugh S.M., Rifkin I.R., Deighton J., Wilson A.B., Lachmann P.J., Lockwood C.M., et al. The immunosuppressive drug thalidomide induces T helper cell type 2 (Th2) and concomitantly inhibits Th1 cytokine production in mitogen- and antigen-stimulated human peripheral blood mononuclear cell cultures. Clin Exp Immunol 99 (1995) 160-167
17. Zheng S.G., Gray J.D., Ohtsuka K., Yamagiwa S., and Horwitz D.A. Generation ex vivo of TGF-beta-producing regulatory T cells from CD4+CD25-precursors. J Immunol 169 (2002) 4183-4189
18. Zeng R., Spolski R., Finkelstein S.E., Oh S., Kovanen P.E., Hinrichs C.S., et al. Synergy of IL-21 and IL-15 in regulating CD8+ T cell expansion and function. J Exp Med 201 (2005) 139-148
19. Kanegasaki S., Nomura Y., Nitta N., Akiyama S., Tamatani T., Goshoh Y., et al. A novel optical assay system for the quantitative measurement of chemotaxis. J Immunol Methods 282 (2003) 1-11
20. Kao J.P., Harootunian A.T., and Tsien R.Y. Photochemically generated cytosolic calcium pulses and their detection by fluo-3. J Biol Chem 264 (1989) 8179-8184
21. Garcia-Vicuna R., Gomez-Gaviro M.V., Dominguez-Luis M.J., Pec M.K., Gonzalez-Alvaro I., Alvaro-Gracia J.M., et al. CC and CXC chemokine receptors mediate migration, proliferation, and matrix metalloproteinase production by fibroblast-like synoviocytes from rheumatoid arthritis patients. Arthritis Rheum 50 (2004) 3866-3877
22. Cooper J.A. Effects of cytochalasin and phalloidin on actin. J Cell Biol 105 (1987) 1473-1478
23. Lee H.Y., Hong Y.K., Yun H.J., Kim Y.M., Kim J.R., and Yoo W.H. Altered frequency and migration capacity of CD4+CD25+ regulatory T cells in systemic lupus erythematosus. Rheumatology (Oxford) 47 (2008) 789-794
24. Mizukami Y., Kono K., Kawaguchi Y., Akaike H., Kamimura K., Sugai H., et al. CCL17 and CCL22 chemokines within tumor microenvironment are related to accumulation of Foxp3+ regulatory T cells in gastric cancer. Int J Cancer 122 (2008) 2286-2293
25. Caterina M.J., and Devreotes P.N. Molecular insights into eukaryotic chemotaxis. FASEB J 15 (1991) 3078-3085
26. Bailly M., and Jones G.E. Polarised migration: cofilin holds the front. Curr Biol 13 (2003) R128-R130
27. Dawe H.R., Minamide L.S., Bamburg J.R., and CrAm L.P. ADF/cofilin controls cell polarity during fibroblast migration. Curr Biol 13 (2003) 252-257
28. Arber S., Barbayannis F.A., Hanser H., Schneider C., Stanyon C.A., Bernard O., et al. Regulation of actin dynamics through phosphorylation of cofilin by LIM-kinase. Nature 393 (1998) 805-809
29. Sanchez-Madrid F., and del Pozo M.A. Leukocyte polarization in cell migration and immune interactions. EMBO J 18 (1999) 501-511
30. Yang N., Higuchi O., Ohashi K., Nagata K., Wada A., Kangawa K., et al. Cofilin phosphorylation by LIM-kinase 1 and its role in Rac-mediated actin reorganization. Nature 393 (1998) 809-812
31. Toshima J., Toshima J.Y., Amano T., Yang N., Narumiya S., and Mizuno K. Cofilin phosphorylation by testicular protein kinase 1 and its role in integrin-mediated actin reorganization and focal adhesion formation. Mol Biol Cell 12 (2001) 1131-1145